newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference

BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laur